Rheumatoid Arthritis (RA) Clinical Research Study
Are you, or someone you know, living with Rheumatoid Arthritis?
Local doctors are recruiting participants to enroll in a clinical research study on an investigational drug, Olokizumab, being tested in difficult to treat subgroups of Rheumatoid Arthritis (RA) patients.
If you or a loved one are over 18 years old, have joints that are swollen and hurting, and other drugs and treatments have not worked adequately, you may qualify for this clinical study.
You may qualify for this clinical study, if you meet the following criteria:
- You are 18 years old or older with a diagnosis of Rheumatoid Arthritis
- You have sore, swollen joints and you have received Methotrexate or a biologic drug, but have not experienced adequate relief of your symptoms
Study-related care and medication will be provided at no cost to qualified participants. Patients may be compensated for travel.